vs
Astrana Health, Inc.（ASTH）与DELUXE CORP（DLX）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是DELUXE CORP的1.8倍（$950.5M vs $535.2M），DELUXE CORP净利率更高（2.2% vs 0.7%，领先1.5%），Astrana Health, Inc.同比增速更快（42.9% vs 2.8%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 0.0%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
德朗士公司是一家美国企业，提供支付处理、数据服务、票据与促销产品以及商户服务，业务分为B2B支付、数据、印刷和商户服务四大板块。截至2025年，公司为数百万中小企业和数千家金融机构提供服务，每年处理支付交易总额超2.8万亿美元，虽传统核心业务为票据印刷等印刷产品，如今支付与数据服务已成为核心板块。
ASTH vs DLX — 直观对比
营收规模更大
ASTH
是对方的1.8倍
$535.2M
营收增速更快
ASTH
高出40.1%
2.8%
净利率更高
DLX
高出1.5%
0.7%
两年增速更快
ASTH
近两年复合增速
0.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $535.2M |
| 净利润 | $6.6M | $12.0M |
| 毛利率 | — | 52.2% |
| 营业利润率 | 1.9% | 8.9% |
| 净利率 | 0.7% | 2.2% |
| 营收同比 | 42.9% | 2.8% |
| 净利润同比 | 184.4% | -5.0% |
| 每股收益（稀释后） | $0.12 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHDLX
| Q4 25 | $950.5M | $535.2M | ||
| Q3 25 | $956.0M | $540.2M | ||
| Q2 25 | $654.8M | $521.3M | ||
| Q1 25 | $620.4M | $536.5M | ||
| Q4 24 | $665.2M | $520.6M | ||
| Q3 24 | $478.7M | $528.4M | ||
| Q2 24 | $486.3M | $537.8M | ||
| Q1 24 | $404.4M | $535.0M |
净利润ASTHDLX
| Q4 25 | $6.6M | $12.0M | ||
| Q3 25 | $373.0K | $33.7M | ||
| Q2 25 | $9.4M | $22.4M | ||
| Q1 25 | $6.7M | $14.0M | ||
| Q4 24 | $-7.8M | $12.6M | ||
| Q3 24 | $16.1M | $8.9M | ||
| Q2 24 | $19.2M | $20.5M | ||
| Q1 24 | $14.8M | $10.8M |
毛利率ASTHDLX
| Q4 25 | — | 52.2% | ||
| Q3 25 | — | 53.9% | ||
| Q2 25 | — | 53.6% | ||
| Q1 25 | — | 52.4% | ||
| Q4 24 | — | 52.3% | ||
| Q3 24 | — | 53.3% | ||
| Q2 24 | — | 53.7% | ||
| Q1 24 | — | 53.0% |
营业利润率ASTHDLX
| Q4 25 | 1.9% | 8.9% | ||
| Q3 25 | 2.0% | 14.0% | ||
| Q2 25 | 3.1% | 11.7% | ||
| Q1 25 | 3.3% | 9.0% | ||
| Q4 24 | 0.1% | 9.0% | ||
| Q3 24 | 5.9% | 7.9% | ||
| Q2 24 | 6.2% | 11.0% | ||
| Q1 24 | 7.5% | 8.3% |
净利率ASTHDLX
| Q4 25 | 0.7% | 2.2% | ||
| Q3 25 | 0.0% | 6.2% | ||
| Q2 25 | 1.4% | 4.3% | ||
| Q1 25 | 1.1% | 2.6% | ||
| Q4 24 | -1.2% | 2.4% | ||
| Q3 24 | 3.4% | 1.7% | ||
| Q2 24 | 3.9% | 3.8% | ||
| Q1 24 | 3.7% | 2.0% |
每股收益（稀释后）ASTHDLX
| Q4 25 | $0.12 | $0.25 | ||
| Q3 25 | $0.01 | $0.74 | ||
| Q2 25 | $0.19 | $0.50 | ||
| Q1 25 | $0.14 | $0.31 | ||
| Q4 24 | $-0.14 | $0.28 | ||
| Q3 24 | $0.33 | $0.20 | ||
| Q2 24 | $0.40 | $0.46 | ||
| Q1 24 | $0.31 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $36.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $680.7M |
| 总资产 | $2.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHDLX
| Q4 25 | $429.5M | $36.9M | ||
| Q3 25 | $463.4M | $25.8M | ||
| Q2 25 | $342.1M | $26.0M | ||
| Q1 25 | $260.9M | $30.3M | ||
| Q4 24 | $290.8M | $34.4M | ||
| Q3 24 | $350.3M | $41.3M | ||
| Q2 24 | $327.7M | $23.1M | ||
| Q1 24 | $337.3M | $23.5M |
股东权益ASTHDLX
| Q4 25 | $779.3M | $680.7M | ||
| Q3 25 | $775.5M | $664.1M | ||
| Q2 25 | $765.5M | $638.7M | ||
| Q1 25 | $745.4M | $622.5M | ||
| Q4 24 | $712.7M | $620.9M | ||
| Q3 24 | $704.6M | $612.7M | ||
| Q2 24 | $678.9M | $620.5M | ||
| Q1 24 | $653.5M | $608.4M |
总资产ASTHDLX
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.2B | $2.6B | ||
| Q2 25 | $1.4B | $2.5B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.3B | $2.6B | ||
| Q2 24 | $1.3B | $2.7B | ||
| Q1 24 | $1.2B | $2.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $102.1M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 8.53× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHDLX
| Q4 25 | $-2.9M | $102.1M | ||
| Q3 25 | $10.0M | $67.1M | ||
| Q2 25 | $90.9M | $51.1M | ||
| Q1 25 | $16.6M | $50.3M | ||
| Q4 24 | $-10.9M | $60.2M | ||
| Q3 24 | $34.0M | $67.9M | ||
| Q2 24 | $23.2M | $39.6M | ||
| Q1 24 | $6.0M | $26.6M |
自由现金流ASTHDLX
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | $27.8M | ||
| Q1 25 | $13.6M | $24.3M | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $46.7M | ||
| Q2 24 | $20.4M | $11.4M | ||
| Q1 24 | $5.6M | $6.1M |
自由现金流率ASTHDLX
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | 5.3% | ||
| Q1 25 | 2.2% | 4.5% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 8.8% | ||
| Q2 24 | 4.2% | 2.1% | ||
| Q1 24 | 1.4% | 1.1% |
资本支出强度ASTHDLX
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | 4.5% | ||
| Q1 25 | 0.5% | 4.8% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | 4.0% | ||
| Q2 24 | 0.6% | 5.2% | ||
| Q1 24 | 0.1% | 3.8% |
现金转化率ASTHDLX
| Q4 25 | -0.44× | 8.53× | ||
| Q3 25 | 26.69× | 1.99× | ||
| Q2 25 | 9.65× | 2.28× | ||
| Q1 25 | 2.48× | 3.59× | ||
| Q4 24 | — | 4.77× | ||
| Q3 24 | 2.11× | 7.60× | ||
| Q2 24 | 1.21× | 1.94× | ||
| Q1 24 | 0.40× | 2.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
DLX
| Services | $247.9M | 46% |
| B2B Payments | $76.3M | 14% |
| Datadrivenmarketingsolutions | $68.5M | 13% |
| Promotional Solutions Revenue | $60.9M | 11% |
| Treasurymanagementsolutions | $59.8M | 11% |
| Other | $17.3M | 3% |
| Other Web Based Solutions | $4.6M | 1% |
